MFN policies are likely to impact more than pricing, and drug companies may alter drug launch plans in the future. With the launch of TrumpRx earlier this year, Americans got their first taste of how ...

Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...

While they may be linked, the administration’s DTC drug coupon site is not necessarily the entirety of its MFN efforts. With the launch of TrumpRx earlier this year, Americans got their first taste of ...

In a new survey of health policy experts conducted by the Cornell Health Policy Center, respondents expressed uncertainty about the effects of a most favored nation (MFN) prescription drug pricing ...

This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks. US ...

The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...

The White House is planning to officially launch its direct-to-consumer, lower-cost drug platform TrumpRx Thursday evening, unveiling the results of President Trump’s “most favored nation” (MFN) drug ...

The MFN executive order aims to reduce US drug prices by aligning them with international prices, facing legal and industry challenges. Pharmacy benefit managers (PBMs) significantly influence US drug ...

President Donald Trump has found himself in an odd juxtaposition as traditional allies are pushing back on his Most Favored Nation (MFN) plan to reduce the price of prescription drugs. In a letter to ...

In an effort to battle against what members feel is an existential threat to their businesses, a group of 10 domestic biotech companies has launched the Midsized Biotech Alliance of America (MBAA) ...